Olfactory Dysfunction: A Clinical Marker of COVID-19

Authors

  • Apar Pokharel College of Medical Sciences, Chitwan, Nepal

DOI:

https://doi.org/10.31729/jnma.5658

Keywords:

anosmia, olfactory dysfunction, SARS-CoV-2

Abstract

Due to the rapid spread of the SARS-CoV-2 virus, many health systems worldwide are overwhelmed, leading to the triggering of the scarcity of medical resources. The identification of indicators that require hospital admission help in the efficient allocation of medical resources. Olfactory impairment is also one of the indicators of COVID-19 infection. Many studies have analyzed olfactory dysfunction in COVID-19 with a variable prevalence rate but underreporting of this problem is very much likely as the problem is considered benign. Many scientific societies have stated that olfactory dysfunction is a frequent symptom of COVID-19 and have published recommendations for it.

Downloads

Published

2021-01-31

How to Cite

Pokharel, A. (2021). Olfactory Dysfunction: A Clinical Marker of COVID-19. Journal of Nepal Medical Association, 59(233), 88–93. https://doi.org/10.31729/jnma.5658

Issue

Vol. 59 No. 233 (2021): JNMA: Published Monthly

Section

Review Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.